Overview
Status
Active
Registry date
2001-09-21
Share capital
722,000.00 PLN
Financials
Revenue history (in m)
Filing timeliness
Financial statements were filed on time, on average 33 days early. All were audited by a statutory auditor.
- 2025filed
- 202401/07/2025
- 202328/06/2024
- 202229/06/2023
- 202104/07/2022
- 202029/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 14.28mMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 378.10kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 12.78mMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 7.88mMedianUSD 608.93kAverageUSD 11.85m
Industry
- Export and import (46.19.Z)
- Intermediation services (46.18.Z)
Offer
- Medical devices
- Diagnostic reagents
- Diagnostic tests
- Life sciences products
- Immunoassays
- Clinical IT systems
Certifications: GMP, ISO 9001
Website technology
- Website
- WordPress
- Analytics and marketing
- Google Tag Manager
Public procurement
257 tenders recorded as contractor: 130 national ($5,229,119) and 127 EU ($24,535,783).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 26, 2026 | Open tender PN/17DzOL/09/2026 for the purchase and supply of reagents and lease of equipment for western blot diagnostics | $286.9K$286,938 | Samodzielny Publiczny Zakład Opieki Zdrowotnej Wojewódzki Szpital Zakaźny w Warszawie | |
| Oct 26, 2026 | SZP.281.23.2026 – Supply of reagent kits and culture media, with equipment rental, for conducting tests for Instytut „CZMP” | $19,689$19,689 | Instytut Centrum Zdrowia Matki Polki | |
| Oct 22, 2026 | “Supply of reagents for detection and diagnostics for the Research Group of Laboratorium Diagnostyki Genetycznej i Mikrobiologicznej under framework agreements, divided into 2 lots” | –– | Sieć Badawcza Łukasiewicz - Port Polski Ośrodek Rozwoju Technologii |
Authorized Representatives
Norbert Krysiuk – Management Board Member
Michaela Weblacher – President of the Management Board
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Biomedica Medizinprodukte Gmbh | 400 | $195,029.71 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2001-06-01.
72 2360 0005 0000 0045 5033 1799- 43 2360 0005 0000 0045 5033 0769
- 96 2360 0005 0000 0045 5033 0785
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 23, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $9,624$9,624 | CTS Customized Training Solutions sp. z o.o. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Qpharmasp. z o.o. | $16,010,159.04 | qpharma.pl | ||
| Vetdirectsp. z o.o. + limited partnership | $14,891,648.32 | vetdirect.pl | ||
| Werfen Polskasp. z o.o. | $14,536,720.51 | werfen.com | ||
| Vitamed Pharmaceuticalssp. z o.o. | $14,515,124.01 | vitamed.pl | ||
| AO East Europesp. z o.o. | $13,998,610.57 | aoeasteurope.pl | ||
| Pharmabestsp. z o.o. | $13,942,252.57 | pharmabest.pl | ||
| PolypharmS.A. | $13,660,727.48 | polypharm.pl | ||
| Medif sp. z o.o.sp. k. | $13,126,958.83 | medif.com | ||
| Centrofarmsp. z o.o. | $13,105,870.20 | centrofarm.pl | ||
| Neomed Polskasp. z o.o. | $8,871,033.54 | neomedpolska.pl |
Change history
| Date | Event | |
|---|---|---|
| 2005-07-04 | Share capital increase (200,000.00 PLN → 722,000.00 PLN) | |
| 2001-09-21 | Entered in the register |
FAQ
Last updated: 2026-10-07